IGM Biosciences Inc (IGMS) — Long-term Investment Intensity

Latest as of September 2021: 1.8%

IGM Biosciences Inc (IGMS) has a Long-term Investment Intensity of 1.8% as of September 2021. Long-term investments of $6.12 Million represent 1.8% of total assets of $332.23 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of IGM Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

1.8%
LT Investments / Total Assets

Long-term Investments

$6.12 Million
USD

Total Assets

$332.23 Million
USD

Country

USA
NASDAQ

IGM Biosciences Inc Long-term Investment Intensity (2019–2019)

This chart shows how IGM Biosciences Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of September 2021, the intensity stands at 1.8%, reflecting long-term investments of $6.12 Million against total assets of $332.23 Million USD. Explore debt repayment capacity of IGM Biosciences Inc to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for IGM Biosciences Inc (2019–2019)

The table below presents the year-by-year Long-term Investment Intensity for IGM Biosciences Inc from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see IGMS market cap overview.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2019 4.6% $11.97 Million $261.35 Million
pp = percentage points